Diabetes Clinical Trials in Illinois

Showing 121-140 of 533 trials

VasQ External Support for Arteriovenous Fistula

NCT03242343

This is a prospective clinical study of the VasQ external support for arteriovenous fistulas. The device is designed to improve fistula outcomes by optimizing the geometrical configuration of the fistula, influencing hemodynamics, minimizing turbulence and promote laminar flow. All patients will be implanted with the VasQ device and will be followed up for a duration of 24 months.

Arterio-Venous FistulaESRDSteal Syndrome+5 more

Laminate Medical Technologies144 participantsStarted Nov 2017

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Peoria, Illinois, United States +12 more locations

TERMINATEDPhase 2108 miles

A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.

NCT05063734

This study is conducted to select the THR-687 dose level (Part A of the study) and to assess the efficacy and safety of the selected dose level compared to aflibercept (Part B of the study).

Diabetes MellitusDiabetic RetinopathyDiabetic Macular Edema

Oxurion16 participantsStarted Aug 2021

Huntington Beach, California, United States • Pasadena, California, United States • Sacramento, California, United States +22 more locations

VasQ External Support for Arteriovenous Fistula

A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.

Diabetes Trials in Other Cities

Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device

Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study

Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM

Family Health History in Diverse Care Settings (FHH)

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

Longitudinal Observation of Insulin Requirements and Sensor Use in Pregnancy

Control-IQ Technology in Individuals With Type 2 Diabetes

Pregnancy Intervention With a Closed-Loop System (PICLS) Study

Look AHEAD: Action for Health in Diabetes

Omnipod Horizon™ Automated Glucose Control System Preschool Cohort

The Effect of In-utero Exposure to Metformin in 5-11 Year Old Offspring of Mothers in the MiTy Trial

Rapid, Non-invasive, Regional Functional Imaging of the Retina. (Diabetic Retinopathy Diagnosis Device)

A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults

The Pediatric Artificial Pancreas (PEDAP) Trial of Control-IQ Technology in Young Children in Type 1 Diabetes

Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes

Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial

Other Conditions in Illinois